Page 5 - Oxford University

Tokyo Olympics 2020 are most costly Summer Games, says Oxford study

The Tokyo Olympics are already the most expensive Summer Games on record with costs set to go higher, a wide-ranging study from Britain's University of Oxford indicates

AstraZeneca expands Covid-19 vaccine supply tie-up with Oxford Biomedica

AstraZeneca has expanded its agreement with Oxford Biomedica to make and supply the drugmaker's COVID-19 vaccine candidate

Five more volunteers join Oxford Covid-19 vaccine clinical trial

Five more volunteers were inoculated with the Oxford Covid-19 vaccine candidate in Pune district as part of the phase II clinical trial launched in search for an antidote against the viral infection

Phase II trial of Oxford Covid vaccine candidate to begin in PGI Chandigarh

The Post Graduate Institute of Medical Education and Research in Chandigarh will be beginning the Phase II trial of oxford Covid-19 vaccine candidate -- Covishield from the first week of September

Clinical trial: Three more volunteers given Oxford Covid-19 vaccine

Three more volunteers were administered the Oxford Covid-19 vaccine candidate at a medical college in Pune as part of the phase II clinical trial of the medicine

Phase II clinical trial of Oxford Covid-19 vaccine begins in Pune

The Phase II clinical trial of the Oxford COVID-19 vaccine, being manufactured by the city-based Serum Institute of India (SII), began at a medical college and hospital here on Wednesday. Two male volunteers were administered the vaccine at Bharti Vidyapeeth's Medical College and Hospital, a senior office-bearer of the hospital said. The trial began around 1 pm, he said. "Doctors at the hospital administered the first shot of the 'Covishield' vaccine to a 32-year-old man after his reports of COVID-19 and antibodies tests came out negative," Medical Director of Bharti Vidyapeeth's Medical College, Hospital and Research Centre, Dr Sanjay Lalwani, said. Another 48-year-old male volunteer was also given the vaccine, he added. While the 32 year-old volunteer works for a private company, the other one is associated with the healthcare sector, he said. "Before administering the vaccine, doctors checked their temperature, blood pressure and heart beats," he said. Five volun

Pune: Phase 2 human trial of Oxford Covid-19 vaccine may start tomorrow

Doses of the potential coronavirus vaccine developed by researchers at Oxford University arrived at the Bharti Vidyapeeth's Medical College in Pune for phase-2 human trials

Coronavirus vaccine update: Russia may partner India for producing vaccines

Coronavirus vaccine's emergency authorisation could be considered if the Indian govt so decides, says ICMR. Catch latest coronavirus vaccine updates here

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

Expects to complete trials by year-end

Rich nations rush to lock up Covid vaccines: What about rest of the world?

Moves by the US and UK to secure supplies from Sanofi and partner GlaxoSmithKline Plc, and another pact between Japan and Pfizer Inc., are the latest in a string of agreements

Oxford vaccine shows protection against Covid-19 in monkeys: Study

A Covid-19 vaccine candidate developed by the University of Oxford in the UK elicits an immune response and reduces the viral load in monkeys exposed to SARS-CoV-2 virus

Adar Poonawalla: A rare risk-taking CEO with strong business acumen

Adar Poonawalla's Serum Institute has tied up with AstraZeneca-backed Oxford vaccine candidate for one billion doses which it will make for India and the GAVI vaccine alliance of 58 countries

Govt to ensure regulatory facilitation for Serum's Covid-19 vaccine trials

Serum Institute of India, the largest vaccine manufacturer in the world, has been chosen by Oxford and its partner AstraZeneca to manufacture the vaccine once it gets ready.

We want to price Covid-19 vaccine below Rs 1,000: Serum Institute CEO

Pune's Serum Institute of India is placing its bets on the Oxford-AstraZeneca vaccine candidate AZD1222

Oxford Covid vaccine trial raises hopes; India testing 10,175/1 mn people

India, which has a population over four times as big as the US', has conducted 14,381,303 tests in total, or just 10,175 tests per 1 million people

Indian medical experts hail Oxford trial results for Covid-19 vaccine

From clinicians to pathology experts, doctors in the country feel the Oxford trials have been the 'most transparent' one by far

Oxford-Astra Covid-19 vaccine shows dual immune action, says researcher

Study shows the vaccine is safe, but it is still too soon to know if it can stop people from being infected

Covid-19 vaccine: Oxford candidate safe, shows immune response in trial

The preliminary results of the phase 1-2 trial, published in The Lancet journal, involved 1,107 healthy adults, and found that the vaccine induced an immune response both via antibodies and T-cells

Britain signs deals with Pfizer, BioNTech, Valneva for Covid-19 vaccines

Deals follow a previously announced agreement with AstraZeneca for the firm to produce 100 million doses of its potential vaccine being developed in partnership with the University of Oxford

Covid-19: Vaccine firms give Moderna a shrug, say no rush on tie-ups

Most players that Business Standard spoke to said they would be concentrating on their own vaccine candidates or the current tie-ups that they have